Private Credit/Industrials, life sciences, agrochemicals, real estate
Edelweiss Special Opportunities Fund III (ESOF III) logo

Edelweiss Special Opportunities Fund III (ESOF III)

Performing private credit fund research profile

Edelweiss Special Opportunities Fund III is EAAA’s third performing-credit vehicle, providing structured financing to established Indian businesses and promoter groups. Public filings and transaction records attribute debt or convertible-debt exposure to Biocon Biologics, Lloyds Metals, Thriveni Earthmovers and a Jindal Saw promoter vehicle. EAAA’s 2026 update reports substantial realisations while two investments remain active.

At a glance

Founded
2019
Footprint
Mumbai
Stage
Performing private credit; structured financing, promoter financing and special situations

Research profile

Read the manager in sequence.

Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.

Investment lens

Edelweiss Special Opportunities Fund III (ESOF III) uses a performing private credit; structured financing, promoter financing and special situations approach across Industrials, life sciences, agrochemicals, real estate.

Current evidence

EAAA reported in July 2026 that ESOF III had realised approximately ₹8,700 crore through 15 of 17 investments and returned 100% of drawn investor capital. Current company filings also document ESOF III positions or exits involving Biocon Biologics, Lloyds Metals, Thriveni Earthmovers and the Jindal Saw promoter vehicle.

Strategy

Performing private credit; structured financing, promoter financing and special situations

Sector focus

Industrials, life sciences, agrochemicals, real estate

AIF structure context

Indian private credit, venture-debt and special-situations funds are commonly structured as Category II AIFs. Verify the specific vehicle and registration before investing.

Current signal

EAAA reported in July 2026 that ESOF III had realised approximately ₹8,700 crore through 15 of 17 investments and returned 100% of drawn investor capital. Current company filings also document ESOF III positions or exits involving Biocon Biologics, Lloyds Metals, Thriveni Earthmovers and the Jindal Saw promoter vehicle.

Investor questions

Edelweiss Special Opportunities Fund III (ESOF III) research questions

What is Edelweiss Special Opportunities Fund III (ESOF III)'s investment strategy?

Edelweiss Special Opportunities Fund III (ESOF III) is covered in Rupeia's private credit research universe. The current public record describes the strategy as Performing private credit; structured financing, promoter financing and special situations, with a sector focus of Industrials, life sciences, agrochemicals, real estate. The profile should be read with the linked source trail and Typical route: Category II AIF context.

What portfolio evidence is available for Edelweiss Special Opportunities Fund III (ESOF III)?

The profile displays only company or asset names attributable to Edelweiss Special Opportunities Fund III (ESOF III) in the reviewed public sources: Biocon Biologics Limited; Lloyds Metals and Energy Limited; Thriveni Earthmovers Private Limited; Jindal Saw promoter holding vehicle. It does not represent a complete current portfolio unless the manager has published one.

What is known about Edelweiss Special Opportunities Fund III (ESOF III)'s performance or track record?

EAAA reported in July 2026 that ESOF III had returned 100% of drawn investor capital after realising approximately ₹8,700 crore through 15 of 17 investments. The remaining investments were described as performing; this is a manager-reported fund milestone, not an independently audited net IRR or DPI disclosure. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.

What are Edelweiss Special Opportunities Fund III (ESOF III)'s fund size, fees and minimum investment?

Public fund size: Approximately ₹6,600 crore at 2020 final close; EAAA reported a ₹7,250 crore fund size in 2026.. Public terms or access information: Closed-ended performing-credit fund investing through secured debt, convertible debentures and structured capital. Vehicle-level fees, carry, hurdle, tenure and audited net-return terms are not publicly disclosed.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.

Who is on Edelweiss Special Opportunities Fund III (ESOF III)'s investment team?

The current source record names Parag Kothari (Fund Manager – Performing Credit); Amit Agarwal (CEO, EAAA Alternatives); Navin Bhutoria; Bishnu Agarwal; Shreyash Deshpande; Parv Garg; Harsha Varma; Vishnu Gupta. Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.

What risks should be reviewed before investing with Edelweiss Special Opportunities Fund III (ESOF III)?

Review borrower concentration, security and seniority, cash versus accrued income, defaults, recoveries, fund leverage and liquidity. The current open diligence point is: The complete 17-investment schedule, current exposure of the two remaining investments, vehicle-level audited net IRR/DPI/TVPI and full security terms are not publicly disclosed. Only transactions directly attributable to ESOF III are retained; broader EAAA platform positions are excluded..

What is the latest public update on Edelweiss Special Opportunities Fund III (ESOF III)?

2026-07-23: EAAA reported in July 2026 that ESOF III had realised approximately ₹8,700 crore through 15 of 17 investments and returned 100% of drawn investor capital. Current company filings also document ESOF III positions or exits involving Biocon Biologics, Lloyds Metals, Thriveni Earthmovers and the Jindal Saw promoter vehicle.

Next step

Need this manager reviewed against your mandate?

Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.

Request independent diligence →